Baytan Birol, Ozdemir Ozlem, Gunes Adalet Meral, Dönmez Osman
Departments of Pediatric Hematology, Uludag University, Bursa, Turkey.
J Pediatr Hematol Oncol. 2010 Mar;32(2):144-6. doi: 10.1097/MPH.0b013e3181bf298b.
Clofarabine has significant efficiency in children with relapsed or refractory leukemia. In previous pediatric trials, various adverse effects have been described. In this case, we report a child with refractory acute lymphoblastic leukemia who developed fatal capillary leak syndrome during clofarabine therapy.
氯法拉滨对复发或难治性白血病患儿有显著疗效。在以往的儿科试验中,已描述了各种不良反应。在此病例中,我们报告了一名难治性急性淋巴细胞白血病患儿,其在氯法拉滨治疗期间发生了致命的毛细血管渗漏综合征。